Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Mogrify
Mogrify is a biopharmaceutical company that has developed a direct cellular reprogramming platform.
Sector
Subsector
Location
total rounds
total raised
NEXEL
NEXEL is a bio-company that focuses on stem cell technologies and develops tools for new drug discovery and treatment of incurable diseases.
Sector
Subsector
Location
total rounds
total raised
Oxford BioMedica
Oxford BioMedica has a pipeline of seven products with the potential to transform treatment landscapes.
Sector
Subsector
Keywords
Location
total rounds
total raised
Tmunity Therapeutics
Tmunity Therapeutics develops novel products to unleash the immunological potential of T cells for treating various diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 29.09.2016. Their latest round Post-IPO Equity
Co-Investors
Investors3
Number of lead investors
Number of investors
Intersouth Partners
Intersouth Partners is a venture capital firm that invests in early-stage technology and life science companies across the Southeast.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Harbert Growth Partners
Harbert Management Corporation is an investment management firm specializing in alternative assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Tall Oaks Capital Partners
Tall Oaks Capital Partners is a venture capital firm specializing in seed and early stage investments in fast-growing technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
John W Holaday
Dr. John Holaday is the Managing Director, CEO, Chief Scientific Officer and founding Director of QRxPharma (QRX, ASX). Previously, he served as co-founder of EntreMed, Inc. (ENMD, NASDAQ) in 1992, Medicis Pharmaceutical Corp. (MRX, NYSE) in 1988. He also founded MaxCyte, Inc. and is a member of the Board of Directors of Neuren (ASX), Pixspan, Plasmonix, CytImmune Sciences and Accelovance. He has raised over $500MM in private and public rounds of financing for these companies that have a collective market capitalization in excess of $2 billion. Dr. Holaday served as a Captain in the US Army, and was at the Walter Reed Army Institute of Research as an officer and civilian for 21 years. Dr. Holaday obtained his BS (1966) and MS (1968) from the University of Alabama (UofA), and his PhD from the University of California, San Francisco in 1976. He was Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine (until 1996) and is Professor of Psychiatry at the Uniformed Services University of the Health Sciences. He is former Chair of the BioAlliance of the Tech Council of Maryland. Dr. Holaday serves on the Leadership Board for the College of Arts and Sciences, UofA, formerly with the Leadership Board of the University of Maryland Biotechnology Institute, and the Judges Panel for the Ernst and Young Entrepreneur of the Year (2003-2007). Dr. Holaday was awarded the Algernon Sydney Sullivan Outstanding Alumnus Award by the University of Alabama (2008), and was named to the Ernst&Young’s Entrepreneur of the Year 2006 Hall of Fame. Dr. Holaday holds over 65 patents and published over 230 scientific articles, book chapters and four books.
current job
organization founded
John W Holaday
Employee Profiles28
Rekha Hemrajani
Board Member, Chair of Compensation Committee
Shruti Abbato
EVP & Business Development, CARMA Cell Therapies, Inc.
Michael Kuo
Vice president of quality and technical operations
Activity
Recent News7
The graph reveals the ratio (%) of positive news articles in a chosen time range